• The No. 51 team has three wins (March 2009, March 2008, October 2007) and one pole (March 2009) in NASCAR Camping World Truck Series competition at Atlanta Motor Speedway.
• Almirola will be racing BBM chassis No. 32. The chassis has two wins (Chicago 2009, Texas 2009) since its debut at Chicagoland Speedway last year. 
• The Atlanta 200 will mark Almirola’s fifth career start at Atlanta Motor Speedway. Almirola has one NSCS start, one NNS start and two NCWTS starts at the famed 1.5-mile oval prior to this weekend.
• Almirola’s best finish at AMS came in 2006. Driving for Wayne Spears’ NCWTS team, Almirola finished in 18th-place.
• In his 30 NCWTS starts at tracks one to two miles in length, Almirola has earned three top-fives and nine top-10 finishes.

“Man, I wish the Truck Series schedule was like the other NASCAR Series. I hate racing and then taking a few weeks off.  I can’t wait to get behind the wheel again.  The AKawareness.com team has shown they’re competitive week-in and week-out.  I’ve got great equipment and great people to work with.”

“It’s great to race in Billy Ballew’s hometown of Atlanta. Where better than here to bring home a victory for Billy? His teams have had a lot of success there..  I know that we’ll be strong this weekend.  The AKawareness.com team has a winning tradition at Atlanta, and I hope to keep it up.

“The track is one of a kind; you can race on the bottom or up against the wall. It gives you an opportunity to find the line that suits the truck the best. It’s such a fast track.  It’s definitely a ‘hold your breath’ track. There’s great side-by-side racing and it seems like the finishes always come down to the wire. It’s going to be exciting for sure.”  -30-

For more information on actinic keratosis (AK) please visit www.AKAwareness.com; ‘Is it AK or OK’ is sponsored by Graceway Pharmaceuticals®.   Graceway’s sponsorship is part of a national public education campaign to raise awareness of actinic keratosis (AK) – a potential early warning sign of skin cancer – as well as the long-term consequences of sun damage over a lifetime.  It is estimated that about 10 million Americans have AK, a common pre-cancer that often develops on skin frequently exposed to the sun.
 Graceway Pharmaceuticals®, LLC, headquartered in Bristol, Tennessee, is dermatology focused pharmaceutical company which focuses on acquiring, in-licensing, and developing branded prescription pharmaceutical products.   Current prescription products marketed by Graceway include Aldara®, Maxair® Autohaler®, and Atopiclair®.. 
Aldara®, Maxair® Autohaler®, Maxair and Design™, Atopiclair, and the Leaf Design® are trademarks owned by or licensed to Graceway Pharmaceuticals, LLC.
For more information on Graceway’s racing program contact: Ben Blessing -Graceway Pharmaceuticals® -ben.blessing@gracewaypharma.com -423-274-2111.